National Cancer Centre Singapore will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Let Us Help

Simply tell us who you are and what you want to do below.

I’m a
Patient Let Us Help
  • Patient
  • Healthcare Professional
  • Caregiver
  • Job Seeker
looking
Select an option

Advancing Cancer Treatment, Care and Research in Singapore

The National Cancer Centre Singapore provides integrated cancer treatment, personalised care and research-driven innovation to improve lives.

Recently Searched Cancer Types

Click a tag for more information on the cancer type

Looking for other cancer types?

In The News

Research Study uncovers the mechanisms behind tumour suppressor BAP1 protein, highlighting new treatment strategies for aggressive cancers A team of scientists led by the National Cancer Centre Singapore (NCCS) and Duke-NUS Medical School (Duke-NUS) has found a new approach for treating some of the world's most aggressive cancers associated with BAP1 mutations.
02 Apr 2026 Read Story
Patient Care Veteran medical social worker Gilbert Fan dies at 67 Veteran medical social worker Gilbert Fan, who served twice as the president of the Singapore Association of Social Workers (SASW), died on March 31 after a battle with colorectal cancer. He was 67 years old.
02 Apr 2026 | The Straits Times Read Story
Patient Care ‘One in a million’ salivary gland cancer took away her sense of taste For over 10 years, Madam Jumidah has been undergoing treatment for a rare cancer of the salivary glands. She is now unable to taste flavours in food.
01 Apr 2026 | The Straits Times Read Story
Research Lucence, DxD Hub and NCCS Launch S$6M Research Collaboration to Advance Cancer Diagnostics Through AI and Patient-Centric Research Precision oncology firm, Lucence, with Diagnostics Development Hub (DxD Hub), hosted by the Agency for Science, Technology and Research (A*STAR), Singapore and the National Cancer Centre Singapore (NCCS), officially launched UNITED 2.0, a S$6 million research collaboration to develop a next-generation, clinical grade cancer profiling test with the goal of advancing the future of precision diagnostics.
13 Mar 2026 Read Story
Upcoming Events